Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
Smith DE |
The Psychotomimetic Amphetamines with Special Reference to DOM (STP) T... |
Journal of Psychedel... |
1969 |
Bhattacharya, S.K., Sanya... |
Investigation on the Hallucinogenic Activity of Indole Alkylamines Iso... |
Indian Journal of Ph... |
1971 |
Consroe PF |
Specific pharmacological management of acute toxicity due to psychedel... |
Arizona Medicine. |
1972 |
Nichols DE, Ilhan M, Long... |
Comparison of Cardiovascular, Hyperthermic, and Toxic Effects of Para-... |
Arch Int de Pharmaco... |
1975 |
Lopatka JE, Brewerton CN,... |
The protective effects of methysergide, 6-hydroxydopamine and other ag... |
Res Commun Chem Path... |
1976 |
Poffenbarger M, Fuller GM |
Effects of Psychotropic Drugs on Neurotubule Assembly |
J.Neurochem. |
1977 |
Da Prada M, Pieri L, Kell... |
Effects of 5,6-Dihydroxytryptamine and 5,7-Dihydroxytryptamine on the ... |
Ann.N.Y.Acad.Sci. |
1978 |
Davis WM, Bedford JA, Bue... |
Acute toxicity and gross behavioral effects of amphetamine, four metho... |
Toxicol Appl Pharmac... |
1978 |
Ricaurte G, Bryan G, Stra... |
Hallucinogenic amphetamine selectively destroys brain serotonin nerve ... |
Science |
1985 |
Wesson DR |
Propylhexedrine |
Drug Alcohol Depend |
1986 |
Davis WM, Hatoum HT, Wate... |
Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevan... |
Alcohol Drug Res |
1987 |
Frith CH, Chang LW, Latti... |
Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the ra... |
Fundam Appl Toxicol |
1987 |
Noggle FT Jr, DeRuiter J,... |
Synthesis, identification, and acute toxicity of some N-alkyl derivati... |
J Assoc Off Anal Che... |
1987 |
Schmidt CJ |
Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphet... |
J Pharmacol Exp Ther |
1987 |
Smilkstein MJ, Smolinske ... |
A case of MAO inhibitor/MDMA interaction: agony after ecstasy |
J Toxicol Clin Toxic... |
1987 |
Stone DM, Hanson GR, Gibb... |
Differences in the central serotonergic effects of methylenedioxymetha... |
Neuropharmacology |
1987 |
Battaglia G, Yeh SY, de S... |
MDMA-induced neurotoxicity: parameters of degeneration and recovery of... |
Pharmacol Biochem Be... |
1988 |
Logan BJ, Laverty R, Sand... |
Differences between rats and mice in MDMA (methylenedioxymethylampheta... |
Eur J Pharmacol |
1988 |
O'Hearn E, Battaglia G, D... |
Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDM... |
J Neurosci |
1988 |
Scallet AC, Lipe GW, Ali ... |
Neuropathological evaluation by combined immunohistochemistry and dege... |
Neurotoxicology |
1988 |
Slikker W Jr, Ali SF, Sca... |
Neurochemical and neurohistological alterations in the rat and monkey ... |
Toxicol Appl Pharmac... |
1988 |
Stone DM, Johnson M, Hans... |
Role of endogenous dopamine in the central serotonergic deficits induc... |
J Pharmacol Exp Ther |
1988 |
Hekmatpanah CR, McKenna D... |
Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced n... |
Neurosci Lett |
1989 |
Johnson M, Stone DM, Bush... |
Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... |
Eur J Pharmacol |
1989 |
Kleven MS, Woolverton WL,... |
Evidence that both intragastric and subcutaneous administration of met... |
Brain Res |
1989 |
Laverty R, Logan BJ |
Ecstasy abuse |
N Z Med J |
1989 |
Lim HK, Foltz RL |
Identification of metabolites of 3,4-(methylenedioxy)methamphetamine i... |
Chem Res Toxicol |
1989 |
Peroutka SJ |
'Ecstasy': a human neurotoxin? |
Arch Gen Psychiatry |
1989 |
Seiden LS, Kleven MS |
Methamphetamine and related drugs: toxicity and resulting behavioral c... |
NIDA Res Monogr |
1989 |
Stone DM, Hanson GR, Gibb... |
In vitro reactivation of rat cortical tryptophan hydroxylase following... |
J Neurochem |
1989 |
Stone DM, Johnson M, Hans... |
Acute inactivation of tryptophan hydroxylase by amphetamine analogs in... |
Eur J Pharmacol |
1989 |
Gibb JW, Stone DM, Johnso... |
Role of dopamine in the neurotoxicity induced by amphetamines and rela... |
NIDA Res Monogr |
1989 |
Kleven MS, Seiden LS |
Toxicity of Amphetamine-related Drugs and Resulting Behavioural Change... |
NIDA Res Monogr |
1989 |
Azmitia EC, Murphy RB, Wh... |
MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for ... |
Brain Res |
1990 |
De Souza EB, Battaglia G,... |
Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... |
Ann N Y Acad Sci |
1990 |
Finnegan KT, Skratt JJ, I... |
The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prev... |
Neurosci Lett |
1990 |
Gaylor DW, Slikker W Jr |
Risk assessment for neurotoxic effects |
Neurotoxicology |
1990 |
Gibb JW, Johnson M, Hanso... |
Neurochemical basis of neurotoxicity |
Neurotoxicology |
1990 |
Gibb JW, Johnson M, Stone... |
MDMA: historical perspectives |
Ann N Y Acad Sci |
1990 |
Grob C, Bravo G, Walsh R |
Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxic... |
Arch Gen Psychiatry |
1990 |
Johnson MP, Huang XM, Obe... |
Behavioral, biochemical and neurotoxicological actions of the alpha-et... |
Eur J Pharmacol |
1990 |
McKenna DJ, Peroutka SJ |
Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine ... |
J Neurochem |
1990 |
Nichols DE, Brewster WK, ... |
Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amph... |
J Med Chem |
1990 |
Nichols DE, Oberlender R |
Structure-activity relationships of MDMA and related compounds: a new ... |
Ann N Y Acad Sci |
1990 |
Oberlender R, Nichols DE |
(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative... |
J Pharmacol Exp Ther |
1990 |
Scheffel U, Ricaurte GA |
Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamin... |
Brain Res |
1990 |
Schmidt CJ, Abbate GM, Bl... |
Selective 5-hydroxytryptamine2 receptor antagonists protect against th... |
J Pharmacol Exp Ther |
1990 |
Schmidt CJ, Black CK, Abb... |
Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methyl... |
Eur J Pharmacol |
1990 |
Schmidt CJ, Black CK, Abb... |
Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity a... |
Brain Res |
1990 |
Schmidt CJ, Black CK, Tay... |
Antagonism of the neurotoxicity due to a single administration of meth... |
Eur J Pharmacol |
1990 |
Chiang CN, Hawks RL |
Research Findings on Smoking of Abused Substances |
NIDA Research Monogr... |
1990 |
McKenna DJ, Guan XM, Shul... |
3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... |
Pharmacol Biochem Be... |
1991 |
Paris JM, Cunningham KA |
Lack of Neurotoxicity after Intra-Raphe Micro-Injections of MDMA ('Ecs... |
NIDA Res Monogr |
1991 |
Johnson MP, Frescas SP, O... |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... |
J Med Chem |
1991 |
Champney TH, Matthews RT |
Pineal serotonin is resistant to depletion by serotonergic neurotoxins... |
J Pineal Res |
1991 |
Huang XM, Johnson MP, Nic... |
Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase) |
Eur J Pharmacol |
1991 |
Johnson MP, Frescas SP, O... |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... |
J Med Chem |
1991 |
Johnson MP, Huang XM, Nic... |
Serotonin neurotoxicity in rats after combined treatment with a dopami... |
Pharmacol Biochem Be... |
1991 |
Nash JF, Nichols DE |
Microdialysis studies on 3,4-methylenedioxyamphetamine and structurall... |
Eur J Pharmacol |
1991 |
Nichols DE, Johnson MP, O... |
5-Iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine |
Pharmacol Biochem Be... |
1991 |
Schmidt CJ, Taylor VL, Ab... |
5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-m... |
J Pharmacol Exp Ther |
1991 |
Steele TD, Brewster WK, J... |
Assessment of the role of alpha-methylepinine in the neurotoxicity of ... |
Pharmacol Biochem Be... |
1991 |
Henry JA, Jeffreys KJ, Da... |
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ('ecstasy') |
Lancet |
1992 |
Grob CS, Bravo GL, Walsh ... |
The MDMA-neurotoxicity controversy: implications for clinical research... |
J Nerv Ment Dis |
1992 |
Hashimoto K, Maeda H, Gor... |
Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-me... |
Brain Res |
1992 |
Hashimoto K, Maeda H, Gor... |
Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity ... |
Eur J Pharmacol |
1992 |
Henry JA |
Ecstasy and the dance of death |
BMJ |
1992 |
Huang X, Marona-Lewicka D... |
p-Methylthioamphetamine is a Potent New Non-Neurotoxic Serotonin-Relea... |
Eur J Pharmacol |
1992 |
Johnson M, Elayan I, Hans... |
Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphet... |
J Pharmacol Exp Ther |
1992 |
Kosten TR, Price LH |
Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use [C... |
Journal of Nervous &... |
1992 |
Nash JF, Yamamoto BK |
Methamphetamine neurotoxicity and striatal glutamate release: comparis... |
Brain Res |
1992 |
Paris JM, Cunningham KA |
Lack of serotonin neurotoxicity after intraraphe microinjection of (+)... |
Brain Res Bull |
1992 |
Ricaurte GA, McCann UD |
Neurotoxic amphetamine analogues: effects in monkeys and implications ... |
Ann N Y Acad Sci |
1992 |
Steele TD, Katz JL, Ricau... |
Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-amin... |
Brain Res |
1992 |
Huang X, Marona-Lewicka D... |
p-methylthioamphetamine is a potent new non-neurotoxic serotonin-relea... |
Eur J Pharmacol |
1992 |
Ali SF, Newport GD, Scall... |
Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produc... |
Neurotoxicol Teratol |
1993 |
Allen RP, McCann UD, Rica... |
Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, '... |
Sleep |
1993 |
Barrett PJ |
'Ecstasy' misuse--overdose or normal dose? |
Anaesthesia |
1993 |
Brodkin J, Malyala A, Nas... |
Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetami... |
Pharmacol Biochem Be... |
1993 |
Colado MI, Murray TK, Gre... |
5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MD... |
Br J Pharmacol |
1993 |
McCann UD, Ricaurte GA |
Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetam... |
J Clin Psychopharmac... |
1993 |
Miller DB, O'Callaghan JP |
The interactions of MK-801 with the amphetamine analogues D-methamphet... |
Ann N Y Acad Sci |
1993 |
Ricaurte GA, Markowska AL... |
3,4-Methylenedioxymethamphetamine, serotonin and memory [published err... |
J Pharmacol Exp Ther |
1993 |
Robinson TE, Castaneda E,... |
Effects of cortical serotonin depletion induced by 3,4-methylenedioxym... |
Neuropsychopharmacol... |
1993 |
Emerson TS, Cisek JE |
Methcathinone: a Russian designer amphetamine infiltrates the rural mi... |
Ann Emerg Med |
1993 |
McDowell DM, Kleber HD |
MDMA: Its history and pharmacology |
Psychiatric Annals |
1994 |
Axt KJ, Mamounas LA, Moll... |
Structural Features of Amphetamine Neurotoxicity in the Brain. Ampheta... |
Academic Press San D... |
1994 |
Bronson ME, Jiang W, Clar... |
Effects of Designer Drugs on the Chicken Embryo and 1-Day-Old Chicken |
Brain Res Bull |
1994 |
Gudelsky GA, Yamamoto BK,... |
Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine rel... |
Eur J Pharmacol |
1994 |
Marsh JCW, Abboudi ZH, Gi... |
Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetami... |
Br J Haematol |
1994 |
McCann UD, Ridenour A, Sh... |
Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (... |
Neuropsychopharmacol... |
1994 |
Miller DB, O'Callaghan JP |
Environment-, drug- and stress-induced alterations in body temperature... |
J Pharmacol Exp Ther |
1994 |
O'Callaghan JP, Miller DB |
Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mou... |
J Pharmacol Exp Ther |
1994 |
Sprague JE, Huang X, Kant... |
Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurot... |
Life Sci |
1994 |
Steele TD, McCann UD, Ric... |
3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and ... |
Addiction |
1994 |
Tucker GT, Lennard MS, El... |
The demethylenation of methylenedioxymethamphetamine ('ecstasy') by de... |
Biochem Pharmacol |
1994 |
House RV, Thomas PT, Bhar... |
Selective modulation of immune function resulting from in vitro exposu... |
Toxicology |
1995 |
McCann UD, Ricaurte GA |
On the neurotoxicity of MDMA and related amphetamine derivatives [lett... |
J Clin Psychopharmac... |
1995 |
Priori A, Bertolasi L, Be... |
Acute dystonic reaction to ecstasy |
Movement Disorders |
1995 |
Miller RT, Serrine SL, Mo... |
Metabolism of 5-(Glutathion-S-yl)-a-methyldopamine Following Intracere... |
Chem Res Toxicol |
1995 |